P24 as a predictor of mortality in a cohort of HIV-1-infected adults in Rural Africa

Journal of Acquired Immune Deficiency Syndromes

Volumn 48, Issue 3, 2008, Pages 345-349

  Erikstrup, Christian ^a,b,h   Kallestrup, Per ^c,d   Zinyama Gutsire, Rutendo B L ^d   Gomo, Exnevia ^d,e   Lüneborg Nielsen, Margrethe ^c   Gerstoft, Jan ^c,f   Schüpbach, Jörg ^g   Ullum, Henrik ^b,f   Katzenstein, Terese L ^c,f  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Department of Clinical Immunology ^*  (Denmark)

^c University of Copenhagen   (Denmark)

^d NATIONAL INSTITUTE OF HEALTH RESEARCH   (Zimbabwe)

^e UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^f UNIVERSITY OF COPENHAGEN   (Denmark)

^g UNIVERSITY OF ZURICH   (Switzerland)

^h AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Africa; HIV; HIV RNA; Mortality; P24

Indexed keywords

ANTIGEN P24; VIRUS RNA; BIOLOGICAL MARKER; GAG PROTEIN;

ADULT; AFRICA; ARTICLE; BLOOD SAMPLING; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RURAL AREA; ACQUIRED IMMUNE DEFICIENCY SYNDROME; EVALUATION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; PREDICTION AND FORECASTING; SURVIVAL; ZIMBABWE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HUMANS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RNA, VIRAL; SURVIVAL ANALYSIS; ZIMBABWE;

EID: 47049101207     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31817dc3d1     Document Type: Article

References (15)

1. UNAIDS Inter-Agency Task Team (IATT) on Education. HIV and AIDS treatment education: a critical component of efforts to ensure universal access to prevention, treatment and care. Available at: http://unesdoc. unesco.org/images/0014/001461/146114e.pdf. Accessed May 1, 2008.
2. Schüpbach J, Tomasik Z, Knuchel M, et al. Optimized virus disruption improves detection of HIV-1 p24 in particles and uncovers a p24 reactivity in patients with undetectable HIV-1 RNA under long-term HAART. J Med Virol. 2006;78:1003-1010.
3. Boni J, Opravil M, Tomasik Z, et al. Simple monitoring of antiretroviral therapy with a signal-amplification-boosted HIV-1 p24 antigen assay with heat-denatured plasma. AIDS. 1997;11:F47-F52.
4. Ledergerber B, Flepp M, Boni J, et al. Human immunodeficiency virus type 1 p24 concentration measured by boosted ELISA of heat-denatured plasma correlates with decline in CD4 cells, progression to AIDS, and survival: comparison with viral RNA measurement. J Infect Dis. 2000; 181:1280-1288.
5. Ondoa P, Dieye TN, Vereecken C, et al. Evaluation of HIV-1 p24 antigenemia and level of CD8+ CD38+ T cells as surrogate markers of HIV-1 RNA viral load in HIV-1-infected patients in Dakar, Senegal. J Acquir Immune Defic Syndr. 2006;41:416-424.
6. Tehe A, Maurice C, Hanson DL, et al. Quantification of HIV-1 p24 by a highly improved ELISA: an alternative to HIV-1 RNA based treatment monitoring in patients from Abidjan, Cote d'Ivoire. J Clin Virol. 2006;37: 199-205.
7. Kallestrup P, Zinyama R, Gomo E, et al. Schistosomiasis and HIV-1 infection in rural Zimbabwe: implications of coinfection for excretion of eggs. J Infect Dis. 2005;191:1311-1320.
8. Schüpbach J, Boni J, Bisset LR, et al. HIV-1 p24 antigen is a significant inverse correlate of CD4 T-cell change in patients with suppressed viremia under long-term antiretroviral therapy. J Acquir Immune Defic Syndr. 2003;33:292-299.
9. Jennings C, Fiscus SA, Crowe SM, et al. Comparison of two human immunodeficiency virus (HIV) RNA surrogate assays to the standard HIV RNA assay. J Clin Microbiol. 2005;43:5950-5956.
10. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992;41:1-19.
11. Kallestrup P, Zinyama R, Gomo E, et al. Schistosomiasis and HIV-1 infection in rural Zimbabwe: effect of treatment of schistosomiasis on CD4 cell count and plasma HIV-1 RNA load. J Infect Dis. 2005;192: 1956-1961.
12. Erikstrup C, Kallestrup P, Zinyama R, et al. Predictors of mortality in a cohort of HIV-1-infected adults in rural Africa. J Acquir Immune Defic Syndr. 2007;44:478-483.
13. Schüpbach J, Tomasik Z, Nadal D, et al. Use of HIV-1 p24 as a sensitive, precise and inexpensive marker for infection, disease progression and treatment failure. Int J Antimicrob Agents. 2000;16:441-445.
14. Zijenah LS, Tobaiwa O, Rusakaniko S, et al. Signal-boosted qualitative ultrasensitive p24 antigen assay for diagnosis of subtype C HIV-1 infection in infants under the age of 2 years. J Acquir Immune Defic Syndr. 2005;39:391-394.
15. Stevens G, Rekhviashvili N, Scott LE, et al. Evaluation of two commercially available, inexpensive alternative assays used for assessing viral load in a cohort of human immunodeficiency virus type 1 subtype C-infected patients from South Africa. J Clin Microbiol. 2005;43: 857-861.